Ironwood Pharmaceuticals Inc said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn severity in a late-stage trial.
Dania Nadeem is a journalist at Seeking Alpha and Reuters. She focuses on critical health topics, particularly the SARS CoV 2 vaccine and COVID-19 testing, providing insightful coverage on the ongoing pandemic. Her work has been featured in prominent publications, including Seeking Alpha and Reuters.




